Vectura Share Discussion Threads

[richman777114] 12/6/2020 15:04

Polaris,sp showing signs of a possible leakadvair generic approval/settlement with GSK?

[vecturaking] 09/6/2020 19:46

vectura inhalers can be used For corona Vaccine


A CORONAVIRUS vaccine developed by scientists at the University of Oxford administered using an inhaler, could be ready by as early as August.

in my view i think Vectura are the leaders in Inhalers will benefit from this in a mega way

hxxps://www.irishpost.com/news/oxford-university-scientists-80-vaccine-will-work-and-it-could-be-ready-in-a-few-weeks-186402

[rolo7] 09/6/2020 18:53

Yep I hold cmcx missed out on fste250 as 888 went above it on last by 1.6million£ difference think it was fixed somehow.

[justiceforthemany] 09/6/2020 17:43

Definite FTSE250 entry territory again - lets hops it is still above this level come September.

[base7] 09/6/2020 11:39

Good point but I would rather our share price increases based on tangible news & the expectation of growing revenues & profits & if we are collaborating in the Covid Arena it would be great to hear of contract /partnership news .
Director spending own cash on shares is a novelty here & I doubt whether £12k stretched him too much but better than nowt

[boadicea] 09/6/2020 11:14

I note that the covid-19 immunisation is suggested to be administerd by inhalation.



Given their expertise in this field, not to mention ample cash resources, I am disappointed that there is no engagement.
At least we could then look forward to some dynanism in the share price judging by other covid related stocks.

[best1467] 08/6/2020 18:44

Well it’s the first positive news out of the blue for along time and halted the fallback to 80p.It would be nice if Hikima could follow up shortly or am I asking to much I live in hope

[justiceforthemany] 08/6/2020 17:12

If this news had been timed to be released last week I reckon we would now be in the FTSE250! Lots of games being played here....

VECTURA SIGNS AGREEMENT WITH AERAMI
Aerami Therapeutics, Inc. (“Aerami”; or the “Company”;) a clinical stage biopharmaceutical company developing inhaled therapies to treat severe respiratory and chronic diseases today announces the signing of a global license and development agreement with Vectura Group plc (LSE: VEC) ("Vectura") to develop and commercialize inhaled imatinib for the treatment of Pulmonary Arterial Hypertension (“PAH”).

Aerami will be responsible for the overall development and commercialization of inhaled imatinib, with Vectura providing a combination of its development services expertise and a license to its FOX® mesh nebulizer technology. The drug device combination product is targeted to go into a Phase 1 trial in the second half of 2020. Aerami plans to pursue orphan disease designation for PAH. In return for the license, the Company will be obligated to pay Vectura certain regulatory and net sales-based milestones, a mid-single digit royalty on global net sales and will purchase FOX® devices from Vectura.

hxxps://www.globenewswire.com/news-release/2020/06/08/2044900/0/en/Aerami-Therapeutics-Signs-a-Global-License-Agreement-with-Vectura-Group-Adding-an-Inhaled-Therapy-for-Patients-with-Pulmonary-Arterial-Hypertension-to-Their-Pipeline.html

[pooroldboy55] 08/6/2020 15:31

Yes all invited free drinks all round .

[polaris] 08/6/2020 14:53

One final point - yet again the number of shares in circulation from the RNS this morning doesn't tally. There must be some more options that have vested, my guess about another 80 k.

[richtea2517] 08/6/2020 14:50

Spring 2017 I reckon

[gbcol] 08/6/2020 14:48

Or - If we get BACK to £1.80 - for us old timers. That seems a lifetime ago :(

[polaris] 08/6/2020 14:48

RE: VR315 (generic Advair). As third entrant to market then you can't expect much above 20 % of the market share and it will introduce further pricing pressure. I'd expect 2021 sales in the region of $30-50 M for Hikma, assuming approval and launch in H2 2020. They will aggressively price match to build up market share. Taking a mid-point sales figure, then you can expect up to $6 M in royalties to VEC in FY2021. Short term the approval milestone will be very welcome.

I'd also expect the approval of QVM149 to appear in the next 1-3 months, also launched pre CY2020 end. It's only a 3 % royalty but every little helps.

I read the GSK reply from a1ord53, sent to my private message inbox. It'll be an interesting one for the judge and process in Delaware. Who is the onus on to prove infringement or not? GSK state it is up to VEC to show in tests the infringement and VEC state it is on GSK to prove otherwise, given the existing ruling. GSK call into question the approach taken by the judge - a dangerous game IMO, although i am not a lawyer. With a bit of luck the initial ruling will come back in a few weeks time, without the need for the judge to hear direct arguments in person, which would entail a longer timescale.

[richtea2517] 08/6/2020 14:43

If we get to £1.80 POB will be throwing a huge party.

[polaris] 08/6/2020 14:37

Excellent news! No, not the RNS today, the fact that we have our own ramper with aligned name. We can finally start to go places as a result. Keep up the randomness there VecturaKing. There is nothing like a bout of ramping above any posts of substance. I am sure that I will learn a thing or two.

[diesel] 08/6/2020 14:15

Back to reality...
Not likely to be a significant earner, but could be a sign that the new team are out there making deals, in which case, very significant.

[vecturaking] 08/6/2020 13:45

VECTURA NUMEROUS JV AND POSSIBLE MERGERS





Good AfterNoon
There are alot of things Going On Behind the scenes in my view

But i would like you guys To Know that Vectura has a great product in its Hands
thats these Smart Inhalers Products

they also have numerous JV partners

we have a sittuation that is THESE SMART INHALERS will be used in a big way to deliver Drugs Directly to the Lungs weather it might be a Vaccine or A TREATMENT like REMESDIVIR of Gilead sciences some people call it the wonder Drug

Vectura are in the best position to reep the rewards
the pharma companys will be queing up to do JOINT VENTURES with the Vectura

dont let it miss your RADAR we ARE going to 180 pence

You can be sure the serious Pharma Companies want to partner with Vectura

[alexchry] 08/6/2020 13:35

Probably not a significant earner but a bit of good news for a change, hope there is more to come.

[justiceforthemany] 07/6/2020 23:12

Could add $30-$40M in royalties p.a. if approved?

Vectura due to receive 16% royalty rate on US sales.

[base7] 07/6/2020 17:41

Sunday Times today tipped Hikma as a good buy & specifically referred to the expected approval of their Advair Generic in the near future.

[diesel] 06/6/2020 13:16

JB...I wouldn’t count on it, something attracted the 3 new members of the management team, apart from our lax system of corporate behaviour.

[jimboyce] 06/6/2020 10:50

Am I correct in assuming that any receipts from The GSK saga will not be included in the measurement of profits for directors share bonuses. I truly hope not as the case was commenced prior to their appointments and the current management have had no input into the result.

[best1467] 05/6/2020 22:43

This as to be one of the Poorest Management teams ever assembled they are nearly invisible have achieved nothing what guidance or leadership as been given since the new additions zero .
The only thing they seem capable of delivering is their wonderful remuneration achievements it’s become that outrageous I can’t even become angry it’s a comedy show